Washington D.C. [USA], Sept 29 (ANI): In a new trial, researchers have discovered that a combination of two immunotherapy drugs -- ipilimumab and nivolumab - is capable of reversing or preventing the progression of advanced melanoma for five years or more in one in every two patients.
Washington D.C. [USA], Apr 1 (ANI): Scientists have found that rare and aggressive neuroendocrine tumours shrink through a combination of two common immunotherapy drugs.
New Delhi [India], Oct. 9 (ANI): An immunotherapy drug has been hailed as a potential 'game changer' after being found to greatly improve survival for patients with relapsed head and neck cancer.